Anti-Thrombotic Effects of Statins in Acute Coronary Syndromes: At the Intersection of Thrombosis, Inflammation, and Platelet-Leukocyte Interactions

Author(s): Travis Sexton, Eric L. Wallace, Susan S. Smyth.

Journal Name: Current Cardiology Reviews

Volume 12 , Issue 4 , 2016

Become EABM
Become Reviewer

Graphical Abstract:


HMG CoA reductase inhibitors, or statins, are standard of care for preventing cardiovascular disease in at-risk populations. Statins are a well-established therapy proven to reduce long-term cardiovascular mortality and morbidity for prevention of secondary cardiovascular events and have become guidelinerecommended therapy following acute myocardial infarction. Emerging data from clinical trials over the last decade indicates that statin therapy may provide broad beneficial effects beyond their primary lipid lowering mechanisms. In coronary heart disease, statins have demonstrated a unique ability to target several cellular pathways, which appear to play an underappreciated role in acute inflammation and subsequent thrombosis. Herein, we review the potential mechanisms where statins may act as antithrombotic agents in the setting of acute coronary syndromes and discuss the clinical implications of these findings.

Keywords: Statin, anti-thrombotic, thrombosis, inflammation, platelets.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Page: [324 - 329]
Pages: 6
DOI: 10.2174/1573403X12666160504100312
Price: $65

Article Metrics

PDF: 28